文献リスト

1）Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009; 6: 524-6

2）National Institute of Health, National Heart, Lung, and Blood Institute Global Initiative for Chronic Obstructive Lung Disease. Global stra­tegy for the diagnosis, management, and preven­tion of chronic obstructive pulmonary disease. Publication number 2701, 2001

3）Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease （GOLD） 2011: 2011 Global Initiative for Chronic Obstructive Lung Disease, Inc; 2011. Available from: http://www. goldcopd. org

4）Hurst JR, Vestbo J, Anzueto A, et al. Suscepti­bility to exacerbation in chronic obstructive pul­monary disease. N Engl J Med. 2010; 363: 1128-38

5）Jones PW, Harding G, Berry P, et al. Develop­ment and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34: 648-54

6）Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2010: CD006103

7）Burge PS, Calverley PM, Jones PW, et al. Rando­mised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000; 320: 1297-303

8）Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994; 272: 1497-505

9）Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med. 1999; 340: 1948-53

10）Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and mode­rate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 1999; 353: 1819-23

11）Cardioselective beta-blockers for chronic obst­ructive pulmonary disease. [database on the Internet]. Cochrane database of systematic reviews. 2005

12）Jabbour A, Macdonald PS, Keogh AM, et al. Differences between beta-blockers in patients with chronic heart failure and chronic obstru­ctive pulmonary disease: a randomized crossover trial. J Am Coll Cardiol. 2010; 55: 1780-7

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp